📄
paper

SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases.

📄 Paper Details
SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases.
["Oltean S", "Gammons M", "Hulse R", "Hamdollah-Zadeh M", "Mavrou A", "Donaldson L", "Salmon A", "Harper S", "Ladomery M", "Bates D"]
Biochemical Society transactions PubMed DOI
Abstract

SRPK1 (serine-arginine protein kinase 1) is a protein kinase that specifically phosphorylates proteins containing serine-arginine-rich domains. Its substrates include a family of SR proteins that are key regulators of mRNA AS (alternative splicing). VEGF (vascular endothelial growth factor), a principal angiogenesis factor contains an alternative 3' splice site in the terminal exon that defines a family of isoforms with a different amino acid sequence at the C-terminal end, resulting in anti-ang...

View on SciDEX ↗